Illinois Code § 410 ILCS 460/131-25

Study.
Open in Lexace · Ask the AI about this section
(a) Before July 1, 2022, and on a
biennial basis thereafter, the Department, with the assistance
of:
 
 
(1) the Center for Minority Health Services;
 
 
(2) health care providers that treat individuals with 
 
sickle cell disease;
 
 
(3) individuals diagnosed with sickle cell disease;
 
 
(4) representatives of community-based organizations 
 
that serve individuals with sickle cell disease; and
 
 
(5) data collected via newborn screening for sickle 
 
cell disease;

shall perform a study to determine the prevalence, impact, and
needs of individuals with sickle cell disease and the sickle cell trait in
Illinois.

 
(b) The study must include the following:
 
 
(1) The prevalence, by geographic location, of 
 
individuals diagnosed with sickle cell disease in Illinois.
 
 
(2) The prevalence, by geographic location, of 
 
individuals diagnosed as sickle cell trait carriers in Illinois.
 
 
(3) The availability and affordability of screening 
 
services in Illinois for the sickle cell trait. 
 
 
(4) The location and capacity of the following for 
 
the treatment of sickle cell disease and sickle cell trait carriers: 
 
 
 
(A) Treatment centers.
 
 
 
(B) Clinics.
 
 
 
(C) Community-based social service organizations.
 
 
 
(D) Medical specialists.

 
 
(5) The unmet medical, psychological, and social 
 
needs encountered by individuals in Illinois with sickle cell disease.
 
 
(6) The underserved areas of Illinois for the 
 
treatment of sickle cell disease. 
 
 
(7) Recommendations for actions to address any 
 
shortcomings in the State identified under this Section.
 
(c) The Department shall submit a report on the study performed
under this Section to the General Assembly.

sickle cell disease;
that serve individuals with sickle cell disease; and
cell disease;
individuals diagnosed with sickle cell disease in Illinois.
individuals diagnosed as sickle cell trait carriers in Illinois.
services in Illinois for the sickle cell trait.
the treatment of sickle cell disease and sickle cell trait carriers:
needs encountered by individuals in Illinois with sickle cell disease.
treatment of sickle cell disease.
shortcomings in the State identified under this Section.

‹ Prev All Illinois sections Next ›


Lexace provides legal information, not legal advice, and no attorney–client relationship is created. Statute text is provided for general information and may not reflect the most recent amendments; verify against the official state code.